0000950123-21-002036.txt : 20210212
0000950123-21-002036.hdr.sgml : 20210212
20210212172516
ACCESSION NUMBER: 0000950123-21-002036
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20201231
FILED AS OF DATE: 20210212
DATE AS OF CHANGE: 20210212
EFFECTIVENESS DATE: 20210212
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vida Ventures Advisors, LLC
CENTRAL INDEX KEY: 0001831423
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-20380
FILM NUMBER: 21629885
BUSINESS ADDRESS:
STREET 1: 40 BROAD STREET
STREET 2: SUITE 201
CITY: BOSTON
STATE: MA
ZIP: 02109
BUSINESS PHONE: 6176489100
MAIL ADDRESS:
STREET 1: 40 BROAD STREET
STREET 2: SUITE 201
CITY: BOSTON
STATE: MA
ZIP: 02109
13F-HR
1
primary_doc.xml
13F-HR
LIVE
0001831423
XXXXXXXX
12-31-2020
12-31-2020
false
Vida Ventures Advisors, LLC
40 Broad Street
Suite 201
Boston
MA
02109
13F HOLDINGS REPORT
028-20380
Y
Certain share holdings that are reported on this 13F were previously reported on a 13F filed by VV Manager, LLC (CIK: 0001735804).
Jean-Philippe Kouakou-Zebouah
Chief Financial Officer
857-254-9492
/s/ Jean-Philippe Kouakou-Zebouah
San Francisco
CA
02-12-2021
0
8
487225
false
INFORMATION TABLE
2
2279.xml
INFORMATION TABLE FOR FORM 13F
Allogene Therapeutics, Inc.
Common Stock
019770106
45386
1798163
SH
SOLE
1798163
0
0
Assembly Biosciences, Inc.
Common Stock
045396108
2723
450000
SH
SOLE
450000
0
0
Dyne Therapeutics, Inc.
Common Stock
26818M108
62161
2960046
SH
SOLE
2960046
0
0
Homology Medicines, Inc.
Common Stock
438083107
8703
770845
SH
SOLE
770845
0
0
Kinnate Biopharma, Inc.
Common Stock
49705R105
109279
2747074
SH
SOLE
2747074
0
0
Kronos Bio, Inc.
Common Stock
50107A104
82600
2765314
SH
SOLE
2765314
0
0
Oyster Point Pharma, Inc.
Common Stock
69242L106
14651
778468
SH
SOLE
778468
0
0
Praxis Precision Medicines, Inc.
Common Stock
74006W108
161722
2939329
SH
SOLE
2939329
0
0